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Abstract
Background: We investigated whether macronutrient composition of energy-restricted diets
influences the efficacy of a telemedically guided weight loss program.
Methods: Two hundred overweight subjects were randomly assigned to a conventional low-fat
diet and a low-carbohydrate diet group (target carbohydrate content: >55% energy and <40%
energy, respectively). Both groups attended a weekly nutrition education program and dietary
counselling by telephone, and had to transfer actual body weight data to our clinic weekly with
added Bluetooth® technology by mobile phone. Various fatness and fat distribution parameters,
energy and macronutrient intake, and various biochemical risk markers were measured at baseline
and after 6, and 12 months.
Results: In both groups, energy intake decreased by 400 kcal/d compared to baseline values within
the first 6 months and slightly increased again within the second 6 months. Macronutrient
composition differed significantly between the groups from the beginning to month 12. At study
termination, weight loss was 5.8 kg (SD: 6.1 kg) in the low-carbohydrate group and 4.3 kg (SD: 5.1
kg) in the low-fat group (p = 0.065). In the low-carbohydrate group, triglyceride and HDL-
cholesterol levels were lower at month 6 and waist circumference and systolic blood pressure
were lower at month 12 compared with the low-fat group (P = 0.005–0.037). Other risk markers
improved to a similar extent in both groups.
Conclusion: Despite favourable effects of both diets on weight loss, the carbohydrate-reduced
diet was more beneficial with respect to cardiovascular risk factors compared to the fat-reduced
diet. Nevertheless, compliance with a weight loss program appears to be even a more important
factor for success in prevention and treatment of obesity than the composition of the diet.
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Background
The burden of overweight (body mass index (BMI) ≥ 25
kg/m2) and obesity (BMI ≥ 30 kg/m2) has dramatically
increased during the last decades [1]. The WHO estimated
that in 2006 worldwide 1.6 billion adults were overweight
and 400 million adults were obese [2]. In the United
States, two in three adults have a BMI ≥ 25 kg/m2 [3]. This
situation is primarily due to an excess energy intake, low
energy expenditure, or both. It has recently been assumed
that high carbohydrate intake, particularly refined carbo-
hydrates, increases the risk of obesity, type 2 diabetes mel-
litus, and metabolic syndrome by exaggerating
postprandial glycemia [4-6].
For several decades, medical societies and governmental
health societies had recommended energy-restricted diets
high in unrefined carbohydrates and fibre to prevent or
treat obesity [7,8]. Based on the aforementioned new
findings, these official recommendations have now been
questioned [9-11]. Several randomized, controlled studies
have shown greater weight loss and better improvement
of cardiovascular risk parameters with energy-restricted
low-carbohydrate diets compared to energy-restricted
low-fat diets after treatment periods of six to twelve
months [12-15].
Beside macronutrient relations, efficacy of weight loss
programs depends on care and control [16]. At present,
the weight watchers program is the only evidenced-based
strategy to treat obesity. Weight loss of 4.3 kg in the par-
ticipants of this program compared to weight loss of only
1.3 kg in the control group has been reported over a
period of twelve months [17]. The SMART (Schlank Mit
Angewandter Telemedizin)-study is based on a telemedi-
cally guided weight loss program that has been estab-
lished at our clinic [18]. Here, we present those results
from the SMART-study, where we have investigated
whether or not a carbohydrate-restricted telemedically
guided weight loss program results in a more pronounced
weight loss and influences metabolic risk markers more
beneficial than a fat-restricted diet does.
Methods
Participants
This study was conducted between December 2005 and
November 2006 at the Heart Center North Rhine-West-
phalia, Institute for Applied Telemedicine, Bad Oeyn-
hausen, Germany. Recruitment began in November 2005
by advertisements in local newspapers and by providing
information sheets at different local health insurance
offices. The criteria for eligibility were an age of 18 to 70
years and a BMI (calculated as weight in kilograms
divided by height in meters squared) > 27 kg/m2. We
excluded patients with a history of any cardiovascular
symptomatology. We also performed an exercise electro-
cardiogram for exclusion of ischemia, and a stress
echocardiography when appropriate. Moreover, we
excluded patients with cholelithiasis, urolithiasis, insulin
dependent diabetes mellitus, and pacemaker implanta-
tion. In addition, pregnancy, lactation, and vegetarianism
were exclusion criteria. Further exclusion criteria were the
participation in another weight loss program and medical
treatment for weight reduction. Of a total number of 298
persons who were initially interested in attending the
study 76 persons refused to participate after a first phone
screening. Additional 16 persons did not meet the inclu-
sion criteria. For the same reason six other persons were
excluded at the baseline investigation at our clinic. In
total, 200 persons were thus included in our study (Figure
1). All participants gave written informed consent to the
study procedures, which were approved by the Ethics
Committee of the Ruhr-University Bochum, Faculty of
Medicine, Germany.
Study design
Participants (n = 200) were randomly assigned by compu-
ter-generated random number lists in two equal groups:
the LOGI group was assigned to a low-carbohydrate diet
developed by Ludwig et al. [9] and modified by Worm
[19]; the DGE group received a conventional low-fat diet
according to recommendations issued by the Deutsche
Gesellschaft für Ernährung [20]. The target macronutrient
composition in the LOGI group was less than 40% of total
energy intake (% energy) from carbohydrates, more than
35% energy from fat, and 25% energy from protein [21].
The target macronutrient composition in the DGE group
was more than 55% energy from carbohydrates, less than
30% energy from fat, and 15% energy from protein. We
instructed all participants in an ambulatory training ses-
sion and delivered diet books to all participants about
their respective diets [19,22,23]. All participants were
advised to reduce their daily energy intake by at least 500
kcal. At study entry, each participant received an electronic
scale (TC-100, I.E.M., Stolberg, Germany, mean deviation
± 0.2 kg with standard deviation of 0.06 kg) with added
Bluetooth® technology. Weekly, the actual body weight
data had to be sent to the Institute of Applied Telemedi-
cine using a mobile phone. The weight reduction program
consisted of weekly nutrition education and dietary coun-
selling by phone with a nutritionist during the first six
months. These calls were standardized according to
weekly items about the respective diet, eating habits, and
weight reduction, which allowed individual and problem-
oriented advice. Each participant arranged her/his own
appointment for weighting and calling. This regular
weekly support was stopped during the second half-year.
The study subjects were responsible for buying and pre-
paring foods by themselves. At baseline, after six months,
and after twelve months, each subject attended an out-
patient medical visit where body weight and height wereCardiovascular Diabetology 2009, 8:36 http://www.cardiab.com/content/8/1/36
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measured in underwear on a calibrated electronic clinical
scale (model 920, SECA GmbH & co. kg., Hamburg, Ger-
many; tolerance ± 0.2 kg). Moreover, waist circumference
was assessed by standard procedures using a 150-cm
anthropometric measuring tape, and body composition
by bioelectrical impedance analysis (Multifrequency Ana-
lyzer Nutrigard M, Data Input GmbH, Darmstadt, Ger-
many). Blood pressure was manually determined using a
cuff and stethoscope. Blood samples were drawn from the
antecubital vein after a 12-h overnight fast. After centrifu-
gation at room temperature for 20 minutes (1500 × g),
aliquots of serum and EDTA-plasma samples were frozen
consecutively and stored at -80°C until analyzed. We
defined the presence of a metabolic syndrome after deter-
mination of waist circumference, blood levels of triglycer-
ides, high density lipoprotein (HDL)-cholesterol, and
fasting plasma glucose, blood pressure, and respective
medical treatment according to current guidelines [24].
Medical history and medical treatment were assessed
using hospital documents.
At baseline and after 1, 3, 6, and 12 months, we assessed
energy and nutrient intake (diet compliance) by the use of
a 3-day validated food record [25] and the amount of
daily physical activity by using a standardized, validated
questionnaire [26]. We calculated metabolic rate by mul-
tiplying the time of exercise with their respective meta-
bolic equivalent (MET) using adequate schedules to
determine METs [27,28].
We considered weight loss and loss of fat mass as primary
endpoints. Metabolic and cardiovascular risk markers
Participant flow through the trial Figure 1
Participant flow through the trial.Cardiovascular Diabetology 2009, 8:36 http://www.cardiab.com/content/8/1/36
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such as waist circumference, blood pressure, blood lipids,
and parameters of glucose metabolism were considered
secondary endpoints.
Biochemical Analyses
We measured serum levels of total cholesterol, high-den-
sity lipoprotein (HDL)-cholesterol, low density lipopro-
tein (LDL)-cholesterol, triglycerides, glucose, and
fructosamine using the Architect autoanalyzer (Abbott,
Wiesbaden, Germany), and glycated hemoglobin
(HbA1c) using the autoanalyzer HA-8160 (Menarini
Diagnostics, Berlin, Germany). We used enzyme-linked
immuno assay kits to assess proinsulin (IBL, Hamburg,
Germany) and adiponectin (R&D Systems GmbH, Wies-
baden-Nordenstadt, Germany). All intra- and interassay
coefficients of variation were below 10.0%.
Statistical Analysis
We expressed categorical variables as percentage rates and
continuous variables as mean ± standard deviation or
standard error of the mean, when appropriate. Because
several variables such as fat-free mass, diastolic and systo-
lic blood pressure, glucose, HbA1c, proinsulin, triglycer-
ides, HDL-cholesterol, and adiponectin were not
normally distributed as tested by the Kolmogorov-Smir-
nov test, these data were normalized using logarithmic
transformation. We used the unpaired t-test to compare
continuous values of the study groups at baseline. For
comparative evaluations of categorical variables, we used
the Chi Square test. Results of anthropometric, clinical,
and biochemical parameters at the 6-month and 12-
month examinations are presented as change from base-
line. The unpaired t-test and the paired t-test were used to
specify those time points with significant differences
between groups or within groups, when appropriate. A 2-
factor analysis of covariance was used to compare anthro-
pometric, clinical, and biochemical parameters between
the LOGI and DGE groups with its respective baseline
value and with fat-free mass and sex distribution as covari-
ates. Data were evaluated following the intention-to-treat
and the per-protocol method. Missing data were replaced
with baseline data in the intention-to-treat analysis. P val-
ues < 0.05 were considered statistically significant. P val-
ues between 0.05 and 0.10 were considered borderline
significant. Considering a standard deviation of 3.5 kg,
the statistical power (α = 0.05; β = 0.80) was sufficient to
detect a difference in body weight of 1.3 kg between the
two study groups. We used SPSS, version 14.0 (SPSS Inc.,
Chicago, IL), to perform the statistical analyses.
Results
Study population
Characteristics at study entry were comparable between
groups, with the exception of sex distribution and fat-free
mass (Table 1). Of the 200 participants, 35 subjects were
lost during follow-up due to non-compliance with the
weight reduction program (n = 23), personal reasons (n =
7), diagnosis of Guillain-Barré syndrome (n = 1), diagno-
sis of a malignancy requiring chemo preventive therapy (n
= 1), and pregnancy (n = 3). The number of drop-outs did
not differ between study groups (P > 0.05) (Figure 1).
Medication use was similar between groups at baseline
(Table 1) and did not change during the study period
(data not shown).
Energy and macronutrient intake and energy expenditure 
(intention-to-treat analysis)
Energy and macronutrient intake and energy expenditure
are shown in Table 2. At baseline, energy intake, energy
expenditure and macronutrient composition were similar
in both groups. During the first six months energy intake
decreased by approximately 400 kcal/d compared to base-
line in both groups. At month 12, mean energy intake had
slightly increased again in both groups but remained
below baseline values. Metabolic rate increased in both
groups. Mean macronutrient composition differed signif-
icantly between both groups from month 1 to month 12.
During the study period, carbohydrate intake was
between 11% and 7% higher in the DGE group compared
with the LOGI group. In addition, the LOGI group had a
4% to 8% higher fat intake and a 2% to 3% higher protein
intake than the DGE group, whereas alcohol intake did
not differ between groups (data not shown). Especially
the DGE group did not achieve the target for carbohydrate
intake (> 55%).
Primary endpoints (intention-to-treat analysis)
Both diets resulted in similar weight loss (Figures 2 and
3). In detail, weight loss was 7.2 ± 5.4 kg in the LOGI
group and 6.2 ± 4.8 kg in the DGE group at month 6. In
the second half-year, mean weight regain was 1.6 kg in the
LOGI group and 1.9 kg in DGE group. Thus, at the end of
the study weight loss was 5.8 ± 6.1 kg in the LOGI group
and 4.3 ± 5.1 kg in the DGE group at month 12, a differ-
ence that reached borderline significance (p = 0.065). In
both groups, approximately 76% of weight reduction was
due to a loss of fat mass.
Secondary endpoints (intention-to-treat analysis)
Waist circumference decreased in both study groups
(Table 3). At month 6, values did not differ between
groups. At month 12, however, the decrease in waist cir-
cumference was more pronounced in the LOGI group
compared with the DGE group even when adjustments
were made for fat-free mass, and sex distribution. Triglyc-
eride levels did not change from baseline to month 6 and
month 12 in the DGE group, but declined in the LOGI
group by 14% at month 6, and 7% at month 12 compared
to baseline values. HDL-cholesterol decreased in the DGE
group until month 6, but rose again in the second half-Cardiovascular Diabetology 2009, 8:36 http://www.cardiab.com/content/8/1/36
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year, whereas this parameter remained unchanged in the
LOGI group. Changes from baseline in triglyceride and
HDL-cholesterol levels differed significantly between the
LOGI and DGE groups at month 6. However, these differ-
ences disappeared later on in the study. Total-cholesterol
was not affected in the LOGI-group but increased in the
DGE group between month 6 and 12. Nevertheless, total
cholesterol did not differ between groups at any time
point. LDL-cholesterol did not change during the entire
study period, neither in the DGE group nor in the LOGI
group. Diastolic blood pressure decreased in both groups,
whereas systolic blood pressure was significantly higher at
month 12 in the DGE group compared with the LOGI
group. The differences in systolic blood pressure at month
12 remained significant after adjustments were made for
fat free mass and sex distribution. Changes in parameters
of glucose metabolism were similar between groups
(Table 3). Results did not differ when the per protocol
method was used (data not shown).
Discussion
In this telemedically guided weight reduction program
both, an energy-restricted high-carbohydrate diet (DGE
group) and an energy-restricted low-carbohydrate diet
(LOGI group) resulted in a satisfactory weight loss and an
improvement of several metabolic parameters over a
period of 12 months. However, weight loss tended to be
greater, and the decline in waist circumference and systo-
lic blood pressure was more pronounced in the LOGI
group than in the DGE group. With respect to HDL-cho-
lesterol and triglycerides, beneficial effects in the LOGI
group compared to the DGE group were only seen at the
6-month follow-up visit. Since mean energy intake and
energy expenditure did not differ between the two groups,
the differences in the aforementioned parameters are
most likely due to differences in macronutrient relations.
The mean body weight loss of 7.2 kg at month 6 and 5.8
kg at month 12 in the LOGI group (Figure 3) was similar
compared to literature reports about efficacy of carbohy-
drate-restricted diets [12-15,29]. In these earlier reports,
results of carbohydrate-restricted diets were also com-
pared with fat-restricted diets. Mean weight loss of the fat-
restricted diets was only 1.6 kg – 3.9 kg at month 6 [12-
15,29] and 2.2 kg – 3.1 kg at month 12 [12,14,29] and
thus lower than the mean weight loss in the energy-
restricted fat-reduced group (DGE group) in our study
(6.2 kg at month 6 and 4.3 kg at month 12, respectively).
It has been assumed that the better 1-year efficacy of car-
bohydrate-restricted diets on weight loss compared to fat-
Table 1: Characteristics of the study groups
Characteristics1 DGE group (n = 100)2 LOGI group (n = 100)2 P value3
Men (n) 24 38 0.032
Age (y) 47 (10.8) 47 (10.3) 0.958
Current smoker (n) 43 44 0.887
Height (m) 1.7 (0.1) 1.7 (0.1) 0.153
Weight (kg) 98.8 (16.9) 100.3 (15.9) 0.526
Body Mass Index (kg/m2) 33.8 (4.8) 33.5 (3.9) 0.665
Fat mass (kg) 40.9 (11.6) 39.3(10.1) 0.314
Fat-free Mass (kg) 57.5 (10.4) 61.0 (12.2) 0.032
Waist circumference (cm) 108.1 (13.1) 109.9 (10.7) 0.277
Heart rate (beats/min) 70.5 (12.1) 69.5 (11.9) 0.537
Systolic blood pressure (mmHg) 128 (14) 126 (13) 0.408
Diastolic blood pressure (mmHg) 86 (8) 86 (8) 0.858
Triglycerides (mmol/l) 1.39 (0.65) 1.31 (0.56) 0.357
Total cholesterol (mmol/l) 5.54 (1.10) 5.50 (0.93) 0.805
LDL-cholesterol (mmol/l) 3.56 (0.91) 3.54 (0.80) 0.635
HDL-cholesterol (mmol/l) 1.46 (0.37) 1.49 (0.37) 0.612
Glucose (mmol/l) 5.62 (0.85) 5.68 (1.09) 0.650
Fructosamine (μmol/l) 284.2 (28.2) 286.1 (26.4) 0.633
HbA1c (%) 5.6 (0.5) 5.6 (0.5) 0.764
Proinsulin (pmol/L) 9.4 (8.9) 11.5 (14.4) 0.217
Adiponectin (μg/ml) 6.7 (3,7) 6.4 (3.5) 0.642
Metabolic syndrome (%) 54.0 45.0 0.203
Drug therapy (%)
- Antihypertensive drugs 31.0 24.0 0.268
- Lipid-lowering drugs 4.0 6.0 0.516
- Antidiabetic drugs 1.0 4.0 0.174
1mean (standard deviation) and percentage, respectively; 2DGE group; high carbohydrate diet; LOGI group; low carbohydrate diet; 3unpaired t-test, 
or Chi-square test when appropriate.Cardiovascular Diabetology 2009, 8:36 http://www.cardiab.com/content/8/1/36
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restricted diets can be explained by a greater energy deficit
in subjects on a low-carbohydrate intake. Since in our
study energy intake and body weight loss were similar in
both groups within the first 6 month, our results are in
line with the aforementioned hypothesis. However,
despite similar energy intake at month 12, weight loss
tended to be greater at month 12 in the LOGI group com-
pared with the DGE group of our study. Note that differ-
ences in macronutrient composition of the diet may
influence resting or postprandial energy expenditure [15].
Since protein intake increases diet-induced thermogene-
sis, it can well be that the slightly higher protein intake in
the LOGI group compared with the DGE group during the
entire study period could also have resulted in a slightly
higher metabolic rate, and thus in a slightly higher weight
loss. Nevertheless, our data also demonstrate that even
with an energy-restricted high-carbohydrate diet a weight
loss similar to an energy-restricted carbohydrate-reduced
diet can be achieved. Importantly, the regain of weight
after 12 months confirms earlier assumptions [17,18] that
continuous intensive care and control is a more important
factor for participants' compliance and, thus, for the suc-
cess of a weight loss program than minor alterations in
macronutrient composition in the diet. Our results are in
line with a very recently published trial by Sacks et al. [30].
They investigated four diets with different macronutrient
relations and showed that weight loss is related to adher-
ence and attendance to instructional sessions. All diets
were equally successful in promoting weight loss and
maintaining weight.
Despite the favourable effects of both diets on weight loss
in our study, the carbohydrate-reduced diet was more
beneficial with respect to some cardiovascular risk mark-
ers such as waist circumference, triglycerides, HDL-choles-
terol, and systolic blood pressure compared to the fat-
reduced diet. Our data show into the same direction than
earlier study results [12-14,29,31,32] but were less pro-
nounced. This may at least in part be due to two factors:
the comparably higher weight loss by carbohydrate-
Table 2: Energy and macronutrient intake and energy expenditure (intention-to-treat analysis)
Variable1 DGE group (n = 100)2 LOGI group (n = 100)2 P value3
Calories (kcal/d)
Baseline 2192 (668) 2140 (696) 0.617
1 month 1759 (468)4 1697 (503)4 0.370
3 months 1755 (478)4 1700 (591)4 0.474
6 months 1783 (597)4 1742 (624)4 0.636
12 months 1854 (624)4 1866 (710)4 0.903
Carbohydrates (% energy)
Baseline 47.1 (7.9) 44.8 (8.6) 0.065
1 month 49.0 (8.2) 37.7 (11.4)4 < 0.001
3 months 49.8 (7.6)4 39.7 (11.0)4 < 0.001
6 months 49.5 (7.6)4 40.9 (10.1)4 < 0.001
12 months 50.1 (8.2)4 43.5 (9.9) < 0.001
Fat (% energy)
Baseline 33.7 (6.9) 35.2 (8.1) 0.169
1 month 30.6 (7.2)4 38.1 (9.2)4 < 0.001
3 months 29.2 (6.5)4 37.1 (9.0) < 0.001
6 months 29.7 (6.5)4 36.5 (9.5) < 0.001
12 months 30.2 (7.0)4 34.2 (8.7) 0.001
Protein (% energy)
Baseline 16.0 (3.9) 16.8 (3.6) 0.164
1 month 17.8 (4.2)4 21.2 (6.1)4 < 0.001
3 months 17.8 (4.0)4 20.0 (4.3)4 < 0.001
6 months 17.7 (4.0)4 19.3 (4.7)4 0.012
12 months 16.7 (3.1) 18.9 (4.4)4 < 0.001
Energy expenditure (kcal/kg/d)
Baseline 32 (5) 31 (6) 0.864
1 month 33 (6)4 33 (7)4 0.876
3 months 34 (6)4 33 (6)4 0.252
6 months 34 (6)4 33 (6)4 0.315
12 months 34 (5)4 33 (6)4 0.618
1mean (standard deviation) and percentage, respectively; 2DGE group; high carbohydrate diet; LOGI group; low carbohydrate diet; 3changes 
between study groups (unpaired t-test); 4change from baseline is significantly different within a subgroup (paired t-test).Cardiovascular Diabetology 2009, 8:36 http://www.cardiab.com/content/8/1/36
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restricted diets in these earlier studies [12,13,29,30], and/
or a more pronounced carbohydrate restriction in the
low-carbohydrate diets used [12-14,29,31].
Low-carbohydrate diets may diminish triglyceride pro-
duction in the liver in response to decreased carbohydrate
delivery [14]. The greater preservation of HDL-cholesterol
on a low-carbohydrate diet may be the result of down-reg-
ulation by dietary fats of those hepatic receptors, which
bind HDL-cholesterol [33]. However, it remains unclear
why HDL-cholesterol and triglycerides differed only at the
6-month visit between the two groups of our study. It may
well be that the transient effects on triglycerides and HDL-
cholesterol are related to differences in macronutrient
composition in our study groups which became smaller
over time (Table 3). Obviously, other variables like waist
circumference and systolic blood pressure were only influ-
enced by the degree of weight loss in the two groups and
not by macronutrient composition (Table 3).
Our results also demonstrate the general problem of
adherence to a diet with extreme nutrition relations. The
use of telemedicine permits continuous contact to partic-
ipants, individual support, and control of weight loss.
Moreover, use of this technique resulted in a low drop-out
rate of only 17% in our study participants. Nevertheless, it
was not possible to achieve the target macronutrient rela-
tions in the two study groups in the long run. The target of
carbohydrate content in the LOGI group (< 40% energy)
was only reached within the first 3 months and the target
of carbohydrate content in the DGE group (>55% energy)
was not reached at any time. Note that earlier investiga-
tions have already reported relatively high attrition-rates
of 30–50% in studies using very low-carbohydrate diets
[12,34]. Despite some additional beneficial effects of
energy-restricted low-carbohydrate diets on cardiovascu-
lar risk markers it appears that poor long-term adherence
to such diets limits its success in clinical practise [34].
It should also be mentioned that the similar loss in body
weight in both groups of our study was associated with a
similar improvement in several metabolic risk markers
such as fat mass, diastolic blood pressure, and glucose,
fructosamine, proinsulin, and adiponectin blood concen-
trations (Table 3). Decreasing insulin resistance and
increasing adiponectin levels reduces atherosclerotic and
inflammatory processes and endothelial dysfunction [35-
37] and may thus have decreased the cardiovascular risk
in both study groups.
Conclusion
Despite the favourable effects of both diets on weight loss,
the carbohydrate-reduced diet was more beneficial with
respect to major cardiovascular risk factors such as central
obesity, triglycerides, HDL-cholesterol, and systolic blood
pressure compared to the fat-reduced diet. Nevertheless,
compliance with a weight loss program appears to be even
a more important factor for success in prevention and
treatment of obesity than the composition of the diet.
Weight loss according to weekly telemetric transfer of body  weight data during the first 6 study months; results are pre- sented as mean ± standard error of the mean Figure 2
Weight loss according to weekly telemetric transfer 
of body weight data during the first 6 study months; 
results are presented as mean ± standard error of 
the mean.
Weight loss in patients on an energy-restricted high-carbohy- drate diet (DGE group) or an energy-restricted low-carbohy- drate diet (LOGI group) at baseline and after 6 and 12  months; results are presented as mean ± standard error of  the mean Figure 3
Weight loss in patients on an energy-restricted high-
carbohydrate diet (DGE group) or an energy-
restricted low-carbohydrate diet (LOGI group) at 
baseline and after 6 and 12 months; results are pre-
sented as mean ± standard error of the mean. P = 
0.198 between groups at month 6, and P = 0.065 between 
groups at month 12.Cardiovascular Diabetology 2009, 8:36 http://www.cardiab.com/content/8/1/36
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Table 3: Changes in body composition, metabolic and cardiovascular risk factors (intention-to-treat analysis)
Variable1 DGE group (n = 100)2 LOGI group (n = 100)2 P value3
Fat mass (kg)
6 months -4.6 (3.7)4 -5.6 (4.2)4 0.073
12 months -3.3 (4.4)4 -4.2 (4.9)4 0.132
Fat free mass (kg)
6 months -1.6 (2.1)4 -1.6 (2.5)4 0.740
12 months -1.3 (3.6)4 -1.5 (2.5)4 0.794
BMI (kg/m2)
6 months -2.1 (1.6)4 -2.3 (1.8)4 0.250
12 months -1.5 (1.8)4 -1.9 (2.1)4 0.110
Waist circumference (cm)
6 months -6.6 (5.3)4 -8.0 (5.5)4 0.083
12 months -4.7 (8.9)4 -6.9 (6.1)4 0.037
Systolic blood pressure (mmHg)
6 months -4 (15)4 -6 (16)4 0.102
12 months -1 (15) -5 (14)4 0.007
Diastolic blood pressure (mmHg)
6 months -3 (9)4 -3 (8)4 0.884
12 months -2 (8)4 -3 (9)4 0.440
Triglyceride (mmol/l)
6 months -0.03 (0.55) -0.18 (0.40)4 0.005
12 months -0.04 (0.50) -0.10 (0.47)4 0.164
Total cholesterol (mmol/l)
6 months -0.07 (0.50) -0.07 (0.56) 0.926
12 months 0.13 (0.61)4 0.03 (0.75) 0.259
LDL-cholesterol (mmol/l)
6 months -0.03 (0.51) -0.03 (0.50) 0.921
12 months 0.06 (0.59) 0.02 (0.65) 0.564
HDL-cholesterol (mmol/l)
6 months -0.09 (0.19)4 -0.02 (0.20) 0.005
12 months -0.03 (0.17) -0.02 (0.21) 0.668
Glucose (mmol/l)
6 months -0.28 (0.59)4 -0.26 (0.76)4 0.475
12 months -0.14 (0.46)4 -0.25 (0.75)4 0.235
HbA1c (%)
6 months -0.2 (0.2)4 -0.2 (0.2)4 0.840
12 months -0.2 (0.2)4 -0.2 (0.2)4 0.314
Fructosamine (μmol/L)
6 months -0.4 (27.5) 1.1 (24.6) 0.960
12 months -5.9 (24.6)4 -8.8 (31.1)4 0.580
Proinsulin (pmol/L)
6 months -1.4 (11.4) -3.7 (14.8) 0.676
12 months -2.2 (8.2)4 -5.0 (14.0)4 0.148
Adiponectin (μg/ml)
6 months -0.2 (3.4) -0.1 (3.0) 0.929
12 months 0.9 (2.7)4 1.3 (2.6)4 0.288
1mean (standard deviation) and percentage, respectively; 2DGE group; high carbohydrate diet; LOGI group; low carbohydrate diet; 3analysis of 
covariance with baseline values as covariates. 4change from baseline is significantly different within a subgroup (paired t-test).Cardiovascular Diabetology 2009, 8:36 http://www.cardiab.com/content/8/1/36
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